Abstract
Journal of Prescribing PracticeVol. 5, No. 5 EditorialContraceptive services for women in the UKPolly MoffatPolly MoffatEditorSearch for more papers by this authorPolly MoffatPublished Online:17 May 2023https://doi.org/10.12968/jprp.2023.5.5.181AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View article References Lederman S, Ottery F, Cano A. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 Apr 1;401(10382):1091–1102 Google ScholarNHS England. NHS Pharmacy Contraception Service Tier 1 – Ongoing supply of oral contraception. 2023. https://www.england.nhs.uk/long-read/nhs-pharmacy-contraception-service-tier-1-ongoing-supply-of-oral-contraception (accessed 4 May 2023) Google Scholar FiguresReferencesRelatedDetails 2 May 2023Volume 5Issue 5ISSN (print): 2631-8385ISSN (online): 2631-8393 Metrics History Published online 17 May 2023 Published in print 2 May 2023 Information© MA Healthcare LimitedPDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
